Starting in March 2020, the COVID-19 pandemic led to drastic public health measures throughout the United States. Individuals who have been previously diagnosed with cancer are likely more drastically affected by the pandemic than the general population. As of January 1, 2019, an estimated 16.9 million cancer survivors were living in the United States, with more than 1.8 million new cancer cases expected in 2020. Individuals currently receiving treatment for cancer have ongoing medical needs forcing them to have regular interactions with the health system and some are making tough decisions about delaying or postponing cancer treatment. Many cancer survivors have received treatments that impact their immune systems or have increased their risk of cardiovascular disease, which are risk factors for COVID-19 complications. The overall focus of the proposed study is to understand how individuals with cancer are impacted by the COVID-19 pandemic compared to the general population.